300 related articles for article (PubMed ID: 31222287)
1. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients.
Di Pasquale MF; Sotgiu G; Gramegna A; Radovanovic D; Terraneo S; Reyes LF; Rupp J; González Del Castillo J; Blasi F; Aliberti S; Restrepo MI;
Clin Infect Dis; 2019 Apr; 68(9):1482-1493. PubMed ID: 31222287
[TBL] [Abstract][Full Text] [Related]
2. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.
Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI;
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314
[TBL] [Abstract][Full Text] [Related]
3. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
[TBL] [Abstract][Full Text] [Related]
4. Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome.
Sousa D; Justo I; Domínguez A; Manzur A; Izquierdo C; Ruiz L; Nebot M; Bayas JM; Celorrio JM; Varona W; Llinares P; Miguez E; Sánchez E; Carratalá J
Clin Microbiol Infect; 2013 Feb; 19(2):187-92. PubMed ID: 22390624
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
[TBL] [Abstract][Full Text] [Related]
6. Risk Factor Evaluation for Methicillin-Resistant
Lewis PO
Ann Pharmacother; 2021 Jan; 55(1):36-43. PubMed ID: 32545992
[TBL] [Abstract][Full Text] [Related]
7. CT findings of pulmonary non-tuberculous mycobacterial infection in non-AIDS immunocompromised patients: a case-controlled comparison with immunocompetent patients.
Lee Y; Song JW; Chae EJ; Lee HJ; Lee CW; Do KH; Seo JB; Kim MY; Lee JS; Song KS; Shim TS
Br J Radiol; 2013 Apr; 86(1024):20120209. PubMed ID: 23440166
[TBL] [Abstract][Full Text] [Related]
8. [Pneumonia in immunocompromised patients].
Mayaud C; Fartoukh M; Parrot A
Rev Prat; 2003 Nov; 53(18):1983-8. PubMed ID: 15008209
[TBL] [Abstract][Full Text] [Related]
9. Infections in patients with aplastic anemia.
Valdez JM; Scheinberg P; Young NS; Walsh TJ
Semin Hematol; 2009 Jul; 46(3):269-76. PubMed ID: 19549579
[TBL] [Abstract][Full Text] [Related]
10. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
11. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.
Aliberti S; Di Pasquale M; Zanaboni AM; Cosentini R; Brambilla AM; Seghezzi S; Tarsia P; Mantero M; Blasi F
Clin Infect Dis; 2012 Feb; 54(4):470-8. PubMed ID: 22109954
[TBL] [Abstract][Full Text] [Related]
12. Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens.
Díaz A; Barria P; Niederman M; Restrepo MI; Dreyse J; Fuentes G; Couble B; Saldias F
Chest; 2007 Mar; 131(3):779-787. PubMed ID: 17356093
[TBL] [Abstract][Full Text] [Related]
13. Fungal infections in the immunocompromised host.
Wanke B; Lazéra Mdos S; Nucci M
Mem Inst Oswaldo Cruz; 2000; 95 Suppl 1():153-8. PubMed ID: 11142705
[TBL] [Abstract][Full Text] [Related]
14. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019.
Certan M; Garcia Garrido HM; Wong G; Heijmans J; Grobusch MP; Goorhuis A
Clin Infect Dis; 2022 Sep; 75(6):1046-1053. PubMed ID: 35195716
[TBL] [Abstract][Full Text] [Related]
16. Clinical study concerning the relationship between community-acquired pneumonia and viral infection in northern Thailand.
Hara K; Yahara K; Gotoh K; Nakazono Y; Kashiwagi T; Imamura Y; Hamada N; Khositsakulchai W; Sanchai T; Khantawa B; Tharavichitkul P; Maneekarn N; Sirisanthana T; Watanabe H
Intern Med; 2011; 50(9):991-8. PubMed ID: 21532221
[TBL] [Abstract][Full Text] [Related]
17. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
[TBL] [Abstract][Full Text] [Related]
18. Antifungal prophylaxis during neutropenia and immunodeficiency.
Lortholary O; Dupont B
Clin Microbiol Rev; 1997 Jul; 10(3):477-504. PubMed ID: 9227863
[TBL] [Abstract][Full Text] [Related]
19. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway.
Holter JC; Müller F; Bjørang O; Samdal HH; Marthinsen JB; Jenum PA; Ueland T; Frøland SS; Aukrust P; Husebye E; Heggelund L
BMC Infect Dis; 2015 Feb; 15():64. PubMed ID: 25887603
[TBL] [Abstract][Full Text] [Related]
20. [Three cases of necrotizing pneumonia by pseudomonas aeruginosa infection in hematological malignancy, including dead and alive cases].
Imataki O; Tamai Y; Abe Y; Kusafuka K; Kawakami K
Gan To Kagaku Ryoho; 2007 May; 34(5):793-7. PubMed ID: 17496460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
